CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $182,793
- in 3 filings
Net −$182,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-08 | Cohen Fred E Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2020-06-08 | BUTITTA CYNTHIA M Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2020-06-08 | Belldegrun Arie Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2020-06-04 | Schoenberg Mark Chief Medical Officer | Exercise or conversion | +1,042 | 18,753 | ||
| 2020-06-04 | Schoenberg Mark Chief Medical Officer | Sale | −349 | $27.51 | $10K | 18,404 |
| 2020-06-04 | Schoenberg Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −1,042 | 2,083 | ||
| 2020-06-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion | +8,807 | 166,272 | ||
| 2020-06-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −8,807 | 167,341 | ||
| 2020-05-20 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion | +1,041 | 7,437 | ||
| 2020-05-20 | PFREUNDSCHUH PETER P. Chief Financial Officer | Sale | −358 | $25.07 | $9K | 7,079 |
| 2020-05-20 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −1,041 | 5,208 | ||
| 2020-05-12 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion | +35,229 | 157,465 | ||
| 2020-05-12 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −35,229 | 176,148 | ||
| 2020-05-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion | +8,808 | 157,465 | ||
| 2020-05-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −8,808 | 176,148 | ||
| 2020-04-27 | Schoenberg Mark Chief Medical Officer | Sale | −70 | $24.35 | $2K | 17,711 |
| 2020-04-27 | PFREUNDSCHUH PETER P. Chief Financial Officer | Sale | −141 | $24.35 | $3K | 6,396 |
| 2020-04-27 | Mullennix Stephen Chief Operating Officer | Sale | −145 | $24.35 | $4K | 10,084 |
| 2020-04-26 | Schoenberg Mark Chief Medical Officer | Exercise or conversion | +208 | 17,781 | ||
| 2020-04-26 | Schoenberg Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −208 | 1,459 |
Page 21 of 25 · 496 trades